Skip to main content

Rat Pure-Blot anti-Mouse IgG (H+L) Secondary Antibody (eB144) [DyLight 680]

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-11664

Novus Biologicals, part of Bio-Techne

Key Product Details

Species Reactivity

Mouse

Applications

Immunocytochemistry/ Immunofluorescence, Immunoprecipitation, Western Blot

Label

DyLight 680 (Excitation = 692 nm, Emission = 712 nm)

Antibody Source

Monoclonal Rat IgG Clone # eB144

Concentration

LYOPH mg/ml

Product Specifications

Immunogen

Mouse IgG

Clonality

Monoclonal

Host

Rat

Isotype

IgG

Description

This secondary antibody Conjugate was prepared from tissue culture supernatant by Protein G affinity chromatography. Assay by Immunoelectrophoresis resulted in a single precipitin arc against Anti-Mouse Serum.

Store vial at 4C prior to restoration. For extended storage aliquot contents and freeze at -20C or below. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4C as an undiluted liquid. Dilute only prior to immediate use.

Scientific Data Images

Western Blot: Rat Pure-Blot anti-Mouse IgG (H+L) Secondary Antibody (eB144) [DyLight 680] [NBP3-11664] - Western Blot of Rat Pure-Blot anti-Mouse IgG (H+L) Secondary Antibody (eB144) [DyLight 680]. Lane 1: Mouse IgG, Non-reduced. Lane 2: Mouse IgG, Reduced. Load: 50 ng per lane. Primary antibody: none. Secondary antibody: Mouse Pure-Blot anti-Rabbit IgG Secondary antibody (eB144) [DyLight 680] at 1:1,000 for 60 min at RT. Block for 30 min at RT. Predicted/Observed size: 160 kDa for Mouse IgG, Non-reduced. Migrates at slightly higher molecular weight. Other band(s): none.
Immunocytochemistry/Immunofluorescence: Rat Pure-Blot anti-Mouse IgG (H+L) Secondary Antibody (eB144) [DyLight 680] [NBP3-11664] - Immunofluorescence microscopy of alpha-tubulin in HeLa cells using Rat Pure-Blot anti-Mouse IgG (H+L) Secondary Antibody (eB144) [DyLight 680] for detection. HeLa cells were fixed with 100% methanol, blocked (5% rat serum/0.3% Triton X-100 in 1X PBS) for 1hr, then incubated with 15ug/mL of anti-alpha-tubulin primary antibody at 4C overnight. Following 3 washes in 1X PBS for 5 min each, 5ug/mL of Rat Pure-Blot anti-Mouse IgG (H+L) Secondary Antibody (eB144) [DyLight 680] was added and allowed to incubate for 1hr at room temperature. Nuclei were counterstained with DAPI present in mounting medium. The predicted main localization is microtubules. Image taken at 63X magnification. (a) Merged alpha-tubulin (red)/DAPI (blue) image shown. (b) secondary antibody only.
Immunocytochemistry/Immunofluorescence: Rat Pure-Blot anti-Mouse IgG (H+L) Secondary Antibody (eB144) [DyLight 680] [NBP3-11664] - Immunofluorescence microscopy of alpha-tubulin in A431 cells using Rat Pure-Blot anti-Mouse IgG (H+L) Secondary Antibody (eB144) [DyLight 680] for detection. A431 cells were fixed with 100% methanol, blocked (5% rat serum/0.3% Triton X-100 in 1X PBS) for 1 hr, then incubated with 15 ug/mL of anti-alpha-tubulin primary antibody at 4 degrees C overnight. After 3 washes in 1X PBS for 5 min each, 5 ug/mL of Rat Pure-Blot anti-Mouse IgG (H+L) Secondary Antibody (eB144) [DyLight 680] was added and allowed to incubate for 1 hr at room temperature. Nuclei were counterstained with DAPI present in mounting medium. The predicted main localization is microtubules. Image taken at 63X magnification. (a) Merged alpha-tubulin (red)/DAPI (blue) image shown. (b) secondary antibody only.

Applications

Application
Recommended Usage

Immunocytochemistry/ Immunofluorescence

1:500 - 1:2500

Western Blot

1:1000
Application Notes
This antibody has been tested in ELISA, immunofluorescence, immunoprecipitation, and western blot and may also be used for detection in immunoassays that do not employ immunoprecipitation. This antibody is provided as a lyophilized powder. To conserve reagent, we recommend incubating the blots from minigels in sealed bags (removing as much air as possible) with minimal volume (2-3 mLs). If used conservatively at 2.5mls/blot will yield enough reagent for 40 blots. Note that there are three key procedural considerations: 1. Protein A or G beads may be used with the mouse, goat and sheep Pure-Blot secondaries, but not with the rabbit Pure-Blot secondary. Use of protein A or G beads with the rabbit Pure-Blot will result in contaminating bands. 2. Immunoprecipitate should be completely reduced. 3. blocking buffer for Fluorescent Western Blotting should be used as the blocking protein for the immunoblot. Note: To achieve best results when detecting mouse IgG1 subtypes, we recommend performing a dot blot or titration to determine the optimal dilution factor for your desired application. All recommended dilutions for listed applications are intended as an initial recommendation, specific conditions for each protein and antibody combination should be specifically optimized by the end user.

Formulation, Preparation, and Storage

Purification

Protein G purified

Reconstitution

Reconstitute with 100 ul deionized water (or equivalent).

Formulation

Lyophilized from 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2, 10 mg/ml Polyethylene Glycol (PEG-8000)

Preservative

0.01% Sodium Azide

Concentration

LYOPH mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store lyophilized antibody at 4C. Aliquot reconstituted liquid and store at -20C. Avoid freeze-thaw cycles.

Background: IgG (H+L)

Antibodies, also known as immunoglobulins (Igs) are critical for immunity and are grouped into five primary classes: IgG, IgM, IgA, IgD, and IgE. The most abundant antibody isotype is immunoglobulin G (IgG) with concentrations ranging from 7.5-22 mg/ml in human serum and has a molecular weight of 150 kDa. The major effector functions of IgG include neutralization, opsonization, complement fixation and antibody dependent cell-mediated cytotoxicity (ADCC). This monomeric immunoglobulin, expressed on the surface of mature B cells, is often depicted as a Y-shape and comprised of 2 heavy chains and 2 light chains linked by disulfide bonds. The heavy chain is type gamma including subtypes gamma 1, gamma 2, gamma 3, and gamma 4 while the light chain is either a kappa or lambda chain. An IgG molecule has two antigen binding sites, each consisting of a heavy and light chain N-terminal variable domain. When combined with the constant heavy chain 1 (Ch1) and the constant light chain domains, it forms the fragment antigen-binding (Fab) region (2 per antibody). The remaining domains (Ch2-Ch4) of both heavy chains make up the Fc region and contain a site for covalently linking an enzymatic or fluorochrome probe, such as HRP or Janelia Fluor 549, for target detection and visualization (1,2,3).

The 4 IgG subclasses, sharing 95% amino acid identity, include IgG1, IgG2, IgG3, and IgG4 for humans and IgG1, IgG2a, IgG2b, and IgG3 for mice. The relative abundance of each human subclass is 60% for IgG1, 32% for IgG2, 4% for IgG3, and 4% for IgG4. In an IgG deficiency, there may be a shortage of one or more subclasses (4).

References

1. Painter RH. (1998) Encyclopedia of Immunology (Second Edition). Elsevier. 1208-1211

2. Chapter 9 - Antibodies. (2012) Immunology for Pharmacy. Mosby 70-78

3. Schroeder H, Cavacini, L. (2010) Structure and Function of Immunoglobulins. J Allergy Clin Immunol. 125(2 0 2): S41-S52. PMID: 20176268

4. Vidarsson G, Dekkers G, Rispens T. (2014) IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 5:520. PMID: 25368619

Alternate Names

IP Detection Reagent

Additional IgG (H+L) Products

Product Documents

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices



DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Secondary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...
Loading...